As Big Tech stocks start to trade more on idiosyncrasies than broad euphoria, Citi says that Nvidia, Microsoft and Apple become especially important to the stock market.

“How can we reconcile these differences?”

The Alibaba empire was once under intense scrutiny from Beijing and competition from rivals. Now a big AI bet is helping it stage a revival.

(RTTNews) - Waldencast plc (WALD) reported second-quarter adjusted EBITDA of $3.3 million, down 47.3% from prior year. Net Revenue increased 5.6% year-over-year to $66.8 million.

In recent trading, shares of SOBO (Symbol: SOBO) have crossed above the average analyst 12-month target price of $27.26, changing hands for $27.41/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or,

(RTTNews) - Precious metals producer Guanajuato Silver Company Ltd. (GSVRF.PK), Monday announced the decision to acquire Bolanitos gold-silver mine in Guanajuato, Mexico from Endeavour Silver Corp. (EDR.TO) for a purchase price of upto $50 million.

(RTTNews) - Atmus Filtration Technologies Inc. (ATMU), a filtration manufacturer and media solutions provider, Monday announced that it has agreed to acquire Koch Filter Corp, a manufacturer of air filtration solutions for growing end-markets, for $395 million in cash, after tax.

In recent trading, shares of Johnson & Johnson (Symbol: JNJ) have crossed above the average analyst 12-month target price of $203.50, changing hands for $203.90/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself.

In recent trading, shares of Kellanova (Symbol: K) have crossed above the average analyst 12-month target price of $83.42, changing hands for $83.45/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or

In recent trading, shares of HCA Healthcare Inc (Symbol: HCA) have crossed above the average analyst 12-month target price of $480.61, changing hands for $491.00/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on

In recent trading, shares of Amkor Technology Inc. (Symbol: AMKR) have crossed above the average analyst 12-month target price of $30.50, changing hands for $32.05/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade o

In recent trading, shares of J.B. Hunt Transport Services, Inc. (Symbol: JBHT) have crossed above the average analyst 12-month target price of $162.96, changing hands for $166.43/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to rea

In recent trading, shares of Ross Stores Inc (Symbol: ROST) have crossed above the average analyst 12-month target price of $170.00, changing hands for $174.00/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on va

In recent trading, shares of Guardant Health Inc (Symbol: GH) have crossed above the average analyst 12-month target price of $100.86, changing hands for $105.33/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on

In recent trading, shares of Regeneron Pharmaceuticals, Inc. (Symbol: REGN) have crossed above the average analyst 12-month target price of $755.22, changing hands for $755.90/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react:

(RTTNews) - Clearside Biomedical, Inc. (CLSD), a biopharmaceutical company, announced Mondday that it has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware.

In recent trading, shares of Sionna Therapeutics Inc (Symbol: SION) have crossed above the average analyst 12-month target price of $42.00, changing hands for $43.66/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade

Inflation can significantly erode the buying power of cash and threaten households' savings over the long term.

BHP made one last-gasp attempt to seduce Anglo but it looks like they have now accepted defeat.

Potential Fed rate cut in December could reignite a ‘risk-on’ flame. Why the market looks to be in ‘early 1999’.

Novo Nordisk’s stock tumbles after its oral GLP-1 drug failed to show much benefit over a placebo against Alzheimer’s.

Carvana’s stunning rebound is facing its biggest test yet: Amazon.

Key PointsSocial Security benefits will increase by 2.8% beginning in 2026.

Key PointsAMD's data center division has lagged behind Nvidia's since the AI arms race began.